ViroCell Biologics

John Hadden, CEO

April 11 | 10:00am | Salone dei Cavalieri, Section 2

London, United Kingdom


ViroCell Biologics is an innovation-driven Contract Development and Manufacturing Organization focused exclusively on the design and GMP manufacture of viral vectors for clinical trials. Built around one of the most prolific academic viral vector manufacturing teams, ViroCell was created to address the global demand for precisely engineered viral vectors and aims to become the partner of choice for companies developing cell and gene therapies. The team leverages its deep track record to help clients to de-risk and accelerate novel cell and gene therapies into and through clinical development, with a mission of being the partner of choice for corporate and academic innovators in this field. Focused initially on manufacturing lentivirus and gamma-retrovirus vectors, ViroCell enables clients to start clinical trials on a scalable platform, delivering value by reducing costs, time and regulatory risk.

By using this website you agree to accept our Privacy Policy and Terms & Conditions